Skip to main content
DP

DIANT Pharma

DIANT Pharma develops continuous processing technology using proprietary DIANT® Jet systems for the scalable production of lipid and polymer-based nanoparticles. This technology enhances the uniformity and quality of nanoparticle drug products and vaccines while reducing manufacturing risks and accelerating time to market.

Ans, United StatesFounded 201914700+ followers
Updated 3 months ago

Funding

$1.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional methods of nanoparticle production for drug delivery and vaccines often suffer from inconsistent particle size and quality, leading to manufacturing inefficiencies and increased risks in product development and scalability. Current batch processes lack the real-time control necessary to ensure uniformity and optimal yield.

Solution

DIANT Pharma offers continuous processing technology leveraging its proprietary DIANT® Jet systems for the scalable manufacturing of lipid and polymer-based nanoparticles. The DIANT® Jet technology enhances nanoparticle uniformity and quality through streamlined control and integrated testing, leading to better medicines and nanoparticle products. Their DIANT® LARU and LiFT systems accelerate R&D, increase efficiency, and reduce cGMP manufacturing risk by enabling automatic inline control of nanoparticle size and characteristics. DIANT® Pharma also offers R&D services and turnkey modular solutions for nanoparticle production.

Target Audience

The primary customers are innovators and CDMOs in the pharmaceutical, vaccine, nutraceutical, food/beverage, and cosmetics industries seeking to improve nanoparticle production for drug delivery and other applications.

Features

  • DIANT® Jet technology for continuous nanoparticle manufacturing.
  • DIANT® LARU: Benchtop system for R&D and academic work.
  • DIANT® LiFT: Commercial system for continuous production of lipid and polymer-based nanoparticles.
  • Automatic inline control of nanoparticle size and characteristics.
  • Integrated testing for real-time quality control.
  • Turnkey modular solutions for nanoparticle production.
This profile is AI-generated and may contain inaccuracies.